|
|
||||||||
1 Department of Molecular and Cellular Physiology, Louisiana State University Medical Center, Shreveport, Louisiana 71130; and 2 Division of Child Development and Rehabilitation, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
We focused on the role
of plasma membrane glutamate uptake in modulating the intracellular
glutaminase (GA) and glutamate dehydrogenase (GDH) flux and in
determining the fate of the intracellular glutamate in the proximal
tubule-like LLC-PK1-F+ cell line. We used
high-affinity glutamate transport inhibitors D-aspartate
(D-Asp) and DL-threo-
-hydroxyaspartate (THA)
to block extracellular uptake and then used
[15N]glutamate or [2-15N]glutamine to
follow the metabolic fate and distribution of glutamine and glutamate.
In monolayers incubated with [2-15N]glutamine (99 atom
%excess), glutamine and glutamate equilibrated throughout the intra-
and extracellular compartments. In the presence of 5 mM
D-Asp and 0.5 mM THA, glutamine distribution remained unchanged, but the intracellular glutamate enrichment decreased by 33%
(P < 0.05) as the extracellular enrichment increased
by 39% (P < 0.005). With glutamate uptake blocked,
intracellular glutamate concentration decreased by 37%
(P < 0.0001), in contrast to intracellular glutamine
concentration, which remained unchanged. Both glutamine disappearance
from the media and the estimated intracellular GA flux increased with
the fall in the intracellular glutamate concentration. The labeled
glutamate and NH
glutamate uptake; X
-hydroxyaspartate; L-[2-15N]glutamine; L-[15N]glutamate; 15NH
This article has been cited by other articles:
![]() |
D. S. C. Raj, P. Zager, V. O. Shah, E. A. Dominic, O. Adeniyi, P. Blandon, R. Wolfe, and A. Ferrando Protein turnover and amino acid transport kinetics in end-stage renal disease Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E136 - E143. [Abstract] [Full Text] |
||||
![]() |
T. Welbourne, E. Friday, R. Fowler, F. Turturro, and I. Nissim Troglitazone acts by PPAR{gamma} and PPAR{gamma}-independent pathways on LLC-PK1-F+ acid-base metabolism Am J Physiol Renal Physiol, January 1, 2004; 286(1): F100 - F110. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Welbourne, R. Routh, M. Yudkoff, and I. Nissim The Glutamine/Glutamate Couplet and Cellular Function Physiology, August 1, 2001; 16(4): 157 - 160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |